Login

Unveiling the Motivations behind Evolis' Intended Sale to HID Group | Emmanuel Picot, CEO of Evolis sa 00:10:00

Share On Facebook Share On Twitter

Emmanuel Picot is Chairman/CEO at Evolis SA.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Investing in Digitalization of Proptech|Sue Xu, Ph.D,Managing Partner,Amino Capital
00:10:00
Using Conviction as a Portfolio Management Tool: Insights from Kelly Ward | Kelly Ward - Senior Associate - Equity Management
00:10:00
The Story Behind General Catalyst's Transformation |Hemant Taneja,CEO,General Catalyst
00:10:00
Maximizing Investment Opportunities: Insights from Justin Hyland | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Updates on OvaSuite®, OvaWatchSM, and EndoCheckTM Discussed in Fireside Chat with CEO| Nicole Sandford, CEO, Aspira Women's Health Inc.
00:10:00
Gem Diamonds: Transforming Production and Maximizing Value
00:10:00
Alexandre Guerrero Discusses Eletromidia's Impact on Brazil's Media Landscape in Mídia Dados | Alexandre Guerrero , CEO , Eletromidia SA.
00:10:00
World Needs More Financial Innovation And Less Financial Engineering.|Micky Malka,Founder,Ribbit Capital
00:10:00
Green Dust Control with Cypher Environmental: Featuring Todd Burns | TODD BURNS - PRESIDENT & CEO at Cypher Environmental Ltd.
00:10:00
Financial Planning Basics with Centry Financial Advisors | Janice Cackowski, President, Centry Financial Advisors, LLC.
00:10:00
Transitioning Investment Banking Strategies: Embracing Advisory Services and Diversification | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
How to Pay for a Fee-Only Financial Advisor with 401(k) and IRA Assets

© 2026 Nehu